[Blood concentrations of thrombomodulin in patients with various diseases]. 1994

N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
1st Department of Internal Medicine, School of Medicine, Tokyo Medical and Dental University.

Concentrations of thrombomodulin in blood plasma were measured by a one-step sandwich enzyme immunoassay (EIA). The concentrations in normal healthy subjects were 9.9 +/- 2.9 ng/ml. The concentrations were found to be significantly higher in patients with SLE, RA and other collagen diseases in their active stages than at their non-active stages. The concentrations increased in patients with DIC, and significantly higher levels were observed when DIC was complicated by multiple organ failure. These findings indicate that plasma concentrations of thrombomodulin may be a useful parameter for vascular injuries caused by inflammatory processes or coagulation/fibrinolysis reactions.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003095 Collagen Diseases Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that "collagen" was equivalent to "connective tissue", but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term "collagen diseases" now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed, p1494) Collagen Disease,Disease, Collagen,Diseases, Collagen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D018180 Thrombomodulin A cell surface glycoprotein of endothelial cells that binds thrombin and serves as a cofactor in the activation of protein C and its regulation of blood coagulation.

Related Publications

N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
September 1994, Nihon Jinzo Gakkai shi,
N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
June 2001, Mycotoxin research,
N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
January 1977, Acta obstetricia et gynecologica Scandinavica,
N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
March 1988, Rinsho byori. The Japanese journal of clinical pathology,
N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
July 1987, Clinica chimica acta; international journal of clinical chemistry,
N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
November 1968, Blood,
N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
March 2004, Clinica chimica acta; international journal of clinical chemistry,
N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
July 1977, Bollettino dell'Istituto sieroterapico milanese,
N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
August 1986, Acta psychiatrica Scandinavica,
N Aoki, and S Ohdama, and S Takano, and M Fujimaki, and K Fukutake, and Y Yoshizawa, and J Murayama, and Y Andou, and T Kawada, and Y Ichikawa
May 1984, Srpski arhiv za celokupno lekarstvo,
Copied contents to your clipboard!